Physician

Elisabeth Petit-Fond Aponte, M.D.

According to 2025 Medicare claims, Elisabeth Aponte, M.D. (NPI: 1871725986) practices ophthalmology in the Duluth, MN-WI market, with the plurality of this provider's patient population coming from St. Louis, MN. This provider's primary affiliated billing organization is LIFEVIEW GLAUCOMA CENTER, P.C. (NPI: 1063064640; TIN: 842370856) and primary practice location at 55811-4448. Aponte is affiliated with the Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Aponte's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 1,191 HCPCS/CPT codes, and received $122,182 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,037 prescription claims across 459 beneficiaries totaling $184,824 in drug costs, led by Rhopressa (Netarsudil Mesylate). Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $701 to $122,182. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $40,655 and ending at $184,824. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	28	39	$701
2016	260	1,113	$79,021
2017	350	1,237	$64,810
2018	305	995	$55,045
2019	255	765	$46,972
2020	90	408	$60,724
2021	158	853	$111,770
2022	201	899	$93,908
2023	207	949	$101,693
2024	199	1,191	$122,182

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	135	459	$40,655
2016	268	1,482	$95,216
2017	418	3,223	$152,850
2018	417	3,105	$175,121
2019	442	3,457	$190,142
2020	286	1,338	$63,925
2021	186	1,126	$61,285
2022	268	1,796	$103,730
2023	400	2,852	$158,728
2024	459	4,037	$184,824

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	163	351	$88
92083	Exam of visual field with extended testing	146	206	$47
92133	Imaging of optic nerve	82	92	$25
92020	Exam of the internal drainage system of eye	61	63	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	68	75	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rhopressa	Netarsudil Mesylate	122	4,608	$48,321
Prednisolone Acetate	Prednisolone Acetate	424	11,044	$14,089
Latanoprost	Latanoprost	961	44,096	$13,165
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	46	1,835	$9,514
Lumigan	Bimatoprost	26	1,070	$9,487

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	NEW WORLD MEDICAL,INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elisabeth Petit-Fond Aponte, M.D.?

Tedicare shows public-source Medicare data for Elisabeth Petit-Fond Aponte, M.D. (NPI 1871725986), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elisabeth Petit-Fond Aponte, M.D. have ACO affiliation data?

Elisabeth Petit-Fond Aponte, M.D. is shown with ACO affiliation data for Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Elisabeth Petit-Fond Aponte, M.D.?

Elisabeth Petit-Fond Aponte, M.D. is linked to LIFEVIEW GLAUCOMA CENTER, P.C. (billing NPI 1063064640) in the available physician profile data.

Does Elisabeth Petit-Fond Aponte, M.D. have Open Payments data?

Elisabeth Petit-Fond Aponte, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.